Our Plan
Foundation and Scientific Basis
In 2013, the International Perinatal Stem Cell Society, Inc. a non-profit (501(c)(3) organization was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many diseases and disorders.
Perinatal stem cell sources include: amnion, amniotic fluid, cord blood, cord tissue/wharton's jelly, as well as placental blood and placental tissue. Perinatal stem cells are formed around the time of birth and are classified as adult stem cells but they really are more primitive then stem cells found in bone marrow or adipose tissue or other traditional sources of adult stem cells and as such, have greater therapeutic potential.
As pioneers in the use of Perinatal stem cells and tissue products we gathered the leading manufactures and drafted this position paper on how we believe we could advance stem cell therapy to the masses through simple regulatory law changes and improvements without compromising safety or efficacy.
